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Abstract 
 
Cystic fibrosis (CF) is a genetic disorder in which the defective gene causes the 
production of unusually thick and viscous mucus that builds-up in the airways, leading to 
impaired ventilation and infection of lung structures. Currently, there is a lack of methods 
capable of routinely assessing, in a regional manner, basic physiological processes that 
occur in the lung, such as pulmonary gas uptake-exchange. The technique described in this 
study makes use of hyperpolarized Xenon-129 (HP Xe-129) gas and chemical shift 
imaging (CSI), for non-invasively obtaining three dimensional regional characterization of 
gas ventilation, and gas uptake-exchange in lung tissue and in red blood cells (RBC). Here 
the feasibility of this method is demonstrated for evaluating Xe-129 distribution in multiple 
lung compartments in subjects with CF and in healthy subjects. 
CSI maps of HP Xe-129 as gas in the airspaces and dissolved in lung tissue and in 
the RBC were generated for each slice of each subject. The ratio of gas dissolved in the 
tissue to that dissolved in the RBC was also obtained, allowing us to infer about pulmonary 
membrane thickness. 
The results demonstrated that healthy subjects presented uniform ventilation and 
gas uptake-exchange in the lung parenchyma and in the RBC. On the other hand, multiple 
regional defects were observed in all lung compartments in the CF population, indicating 
that current CSI map resolution is sufficient to detect focal disease. Xe-129 CSI 
quantification was capable of clearly distinguishing CF from healthy population. CF 
subjects presented a higher tissue/RBC ratio, probably due to inflammation of the lung 
tissue walls.  
The preliminary data presented here let us hypothesize that this technique is able to 
provide, in a single short breath-hold, detailed physiological information, with potential to 
detect small changes in the progression of various pulmonary diseases. 
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Resumo 
 
Fibrose cística é a doença hereditária mais comum e fatal que afecta a população 
caucasiana. Esta patologia é causada por mutações no gene que codifica a proteína 
responsável pela produção do suor, sucos digestivos e muco. Geralmente, mutações neste 
gene provocam um transporte anormal de iões através do epitélio das vias aéreas, causando 
a produção de muco excessivamente espesso e viscoso. Em vez de servir como 
lubrificante, o muco obstrui as vias áreas, dificultando a ventilação e levando ao 
desenvolvimento de infecções crónicas. A natureza viscosa deste muco também afecta o 
sistema digestivo, uma vez que obstrui o pâncreas, impedindo que as enzimas cheguem aos 
intestinos. Estima-se que, a nível mundial, cerca de 70,000 crianças e jovens adultos sejam 
afectados pela fibrose cística, com 30,000 casos apenas nos Estados Unidos da América. A 
fibrose cística é tipicamente diagnosticada na infância e a actual esperança média de vida 
encontra-se, aproximadamente, nos 37 anos.  
Actualmente, grande parte dos métodos para diagnóstico e monitorização de 
doenças pulmonares fornecem apenas uma medida global da função pulmonar, como 
ocorre no caso da espirometria. Por outro lado, a maioria das técnicas de imagiologia, 
usadas para avaliar as alterações morfológicas das vias áreas e parênquima pulmonar, dão 
informação a nível regional, mas requerem o uso de radiação ionizante. Este factor é 
altamente indesejável, considerando a necessidade da realização frequente de exames na 
população pediátrica, que é mais sensível às propriedades carcinogénicas da radiação 
ionizante.  
Hélio-3 e Xénon-129 hiperpolarizados têm sido usados como agentes de contraste 
em ressonância magnética durante mais de uma década, possibilitando a geração de 
imagens do sistema respiratório, através desta técnica. O facto de não envolverem radiação 
ionizante torna a utilização destes gases para monitorização de doenças pulmonares muito 
apelativa. Apesar do uso de Xénon-129 ter sido limitado pela reduzida intensidade de sinal 
que gerava em ressonância magnética em comparação com o Hélio-3, o seu custo reduzido 
devido à sua abundância natural e as recentes melhorias nas técnicas de polarização fazem 
com que este gás seja fortemente considerado para uso em imagiologia médica.  
Todavia, a propriedade mais atraente do Xénon-129 é a sua solubilidade em tecidos 
que contenham água e lípidos, permitindo que se difunda facilmente através das 
membranas celulares. Uma vez inalado, a maior parte do Xénon-129 permanece sob forma 
de gás nos alvéolos, enquanto 1 a 2% dissolve-se no parênquima pulmonar e nos glóbulos 
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vermelhos do sangue. Dado que a frequência de ressonância do Xénon-129 é fortemente 
influenciada pelo meio, um desvio químico ocorre para este gás em diferentes 
compartimentos pulmonares: a frequência do Xénon-129 dissolvido no tecido e nos 
glóbulos vermelhos é desviada de cerca de 200 partes por milhão da frequência do Xénon-
129 sob forma de gás, tornando possível diferenciar as fases gasosa e dissolvida, através de 
espectroscopia. Deste modo, a quantidade relativa de Xénon-129 em cada compartimento 
pode ser deduzida através da frequência e integral do sinal gerado.  
A técnica descrita neste trabalho é denominada de 3D SB-CSI (imagiologia 
tridimensional por desvio químico numa inalação) e foi desenvolvida pelo grupo do 
Departamento de Radiologia e Imagiologia Médica da Universidade da Virgínia. A 3D SB-
CSI combina o uso de Xénon-129 hiperpolarizado com espectroscopia por ressonância 
magnética para obter, numa só inalação, informação regional acerca da distribuição de gás 
nos alvéolos e da absorção e/ou troca do mesmo pelo tecido e glóbulos vermelhos. A 
implementação desta técnica tem como finalidade a detecção de alterações fisiológicas que 
possam ocorrer nível da ventilação, estrutura do tecido ou fluxo sanguíneo derivadas de 
uma condição patológica. Desta forma, é possível a obtenção de imagens de alta resolução 
que permitem a avaliação de uma das funções fisiológicas pulmonares mais básicas, de 
uma forma não-invasiva, não recorrendo ao uso de radiação ionizante.  
Este estudo teve como objectivo demonstrar a eficácia da 3D SB-CSI para avaliar a 
distribuição de Xénon-129 nos diferentes compartimentos pulmonares em sujeitos com 
fibrose cística e em sujeitos saudáveis.    
Nove estudos clínicos independentes foram realizados em sete voluntários: três 
saudáveis, três previamente diagnosticados com fibrose cística e um indivíduo fumador 
passivo, para investigar se a 3D SB-CSI é sensível a outros tipos de doenças respiratórias; 
um indivíduo saudável e um com fibrose cística foram examinados duas vezes para 
determinar a repetibilidade da técnica. Mapas de Xénon-129 hiperpolarizado como gás nos 
alvéolos e dissolvido no tecido e nos glóbulos vermelhos foram gerados para cada sujeito. 
Foi, igualmente, obtida a razão entre o gás dissolvido no tecido e nos glóbulos vermelhos, 
permitindo-nos inferir acerca da espessura da membrana pulmonar, que pode ser 
aumentada devido aos processos inflamatórios que ocorrem na fibrose cística. 
Os resultados obtidos demonstraram uma distribuição de Xénon-129 nos alvéolos, 
tecido e glóbulos vermelhos uniforme, nos indivíduos saudáveis. A 3D SB-CSI também foi 
capaz de detectar um gradiente de intensidade crescente entre zonas mais anteriores e 
zonas mais posteriores dos pulmões, possivelmente atribuível ao efeito da gravidade mais 
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acentuado nas zonas dependentes. Estes gradientes fisiológicos são normais e já foram 
demonstrados em outros estudos em indivíduos saudáveis. 
 Por outro lado, vários defeitos, identificados pela redução ou inexistência de sinal, 
foram observados nos mapas de todos os compartimentos pulmonares nos sujeitos com 
fibrose cística, indicando que a actual resolução da imagem é suficiente para detectar 
alterações regionais. Foi, também, possível detectar a falta de gradiente causado pelo efeito 
da gravidade num sujeito em estágio mais avançado de fibrose cística. 
A análise da alteração da espessura da membrana pulmonar com a doença 
demonstrou ser um método fiável para distinguir os sujeitos saudáveis e os com fibrose 
cística. Uma menor absorção e/ou troca de gás entre o tecido e os glóbulos vermelhos foi 
observada nos indivíduos com fibrose cística, provavelmente devido à inflamação da 
membrana pulmonar. Através o cálculo da razão entre a quantidade de gás dissolvido no 
tecido e nos glóbulos vermelhos, foi igualmente possível detectar doença no fumador 
passivo, não detectável na espirometria nem em imagens de ventilação convencionais 
utilizando Xénon-129. Estes resultados sugerem que a 3D SB-CSI poderá fornecer 
informação adicional útil para diagnosticar patologias que afectem a absorção e/ou troca de 
gases, como no caso em que ocorrem alterações ao nível da membrana pulmonar. 
Esta técnica também demonstrou ser capaz de obter resultados reprodutíveis tanto 
para a população saudável como para a com fibrose cística. O indivíduo com patologia 
esteve associado a diferenças médias mais elevadas entre aquisições consecutivas, o que 
era esperado, dado que sujeitos com doenças pulmonares têm dificuldade em reproduzir os 
movimentos respiratórios. 
Os resultados preliminares apresentados neste estudo permitem-nos supor que a 3D 
SB-CSI é capaz de fornecer informação detalhada ao nível da fisiologia pulmonar, em 
apenas uma inalação de gás e sem recurso a radiação ionizante. Uma vez que a maioria das 
técnicas de imagiologia usadas para monitorizar as doenças respiratórias não são 
recomendadas para a população pediátrica, devido às suas potenciais propriedades 
carcinogénicas, esta técnica pode tornar-se no método de escolha para avaliação de 
doenças pulmonares, em particular para o caso de fibrose cística.     
Com o desenvolvimento de novas estratégias terapêuticas para o tratamento de 
fibrose cística, surge uma necessidade crescente de um melhor conhecimento da fisiologia 
pulmonar e mecanismos de progressão da doença. Para além disso, a avaliação da eficácia 
destas terapias tem sido restringida, devido às limitações dos actuais métodos de 
monitorização. Uma vez que a maior parte da investigação nesta área tem se focado em 
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estratégias anti-inflamatórias, a implementação da 3D SB-CSI poderá proporcionar um 
prognóstico mais precoce acerca do efeito do tratamento, já que demonstrou ser sensível a 
esta condição.   
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Introduction 
 
Cystic fibrosis (CF) is the most frequent lethal genetic disorder in Caucasians that 
primarily affects the lungs and digestive system. This disorder is characterized by 
mutations in the CF gene that cause the production of abnormally thick and viscous mucus. 
The obstruction of the airways by this mucus predisposes the individuals to chronic lung 
infections, which lead to progressive loss of pulmonary function. 
Current methods of pulmonary disease diagnosis and monitoring tend to focus 
primarily on the lung as a whole, and predominantly on ventilation parameters, which are 
easier to assess, as in the case of pulmonary function tests. Most of the imaging techniques 
used for probing the morphological changes of the airways and the lung parenchyma 
provide regional information, but require the use of ionizing radiation. This is a highly 
undesirable feature considering the need for repeated assessments for intervention or 
therapy. 
The method demonstrated in this work was pioneered by the group at the 
Department of Radiology and Medical Imaging of the University of Virginia and is termed 
three dimensional Single Breath-hold Chemical Shift Imaging (3D SB-CSI). This method 
makes use of hyperpolarized Xenon-129 gas and magnetic resonance spectroscopic 
imaging, for non-invasively, obtaining regional characterization of basic pulmonary 
physiological processes within the lung, as ventilation and gas uptake-exchange in multiple 
lung compartments, without the use of radioactive substances or ionizing radiation.  
The aim of this study is to demonstrate the feasibility of this technique for assessing 
ventilation and gas uptake-exchange in lung tissue and in red blood cells in subjects with 
cystic fibrosis and in healthy subjects.  
In chapter I, a brief introduction about hyperpolarized gas imaging, with focus on 
Xenon-129 as a contrast agent, will be done to contextualize the reader about this recent 
imaging technique. More specifically, previous work relating spectroscopy and Xenon-129 
will be described in order to point out the underlying fragilities and how they were 
overcome in the 3D SB-CSI technique.  
In the second chapter, a potential clinical application of the 3D SB-CSI technique 
will be discussed for detecting regional disease on CF subjects. The use of this technique 
will also be demonstrated in a subject with high second-hand smoking exposure. The 
Regional Quantification of Lung Function in Cystic Fibrosis using hyperpolarized Xenon-129 and 
Chemical Shift Imaging  
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methods used to analyze the spectroscopy data, successful in distinguishing healthy from 
diseased subjects will be outlined, as other attempts done during the course of this study. 
Finally, the obtained results will be presented and discussed, as well as, further 
improvements necessary for optimization of this technique.        
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Chapter I: 
 Hyperpolarized Xenon-129 and chemical shift imaging to 
evaluate lung physiology 
 
 
1.1 Magnetic resonance lung imaging: general considerations 
 
Clinical imaging of the lungs has been performed with chest radiography, 
Computed Tomography (CT), Single Photon Emission Computed Tomography (SPECT) 
or scintigraphy, involving the use of ionizing radiation, inhalation of radioactive gases and 
aerosols [1]. Whereas CT and radiography imaging are mostly restricted to morphologic 
studies, functional nuclear medicine studies are limited by spatial and temporal resolution 
(Table 1). More recently, functional pulmonary studies have been achieved with Positron 
Emission Tomography (PET), capable of providing regional high-sensitivity mapping of 
ventilation and perfusion. However, increased exposure to ionizing radiation is a major 
drawback, especially for longitudinal studies for intervention or therapy [1].    
In the past, magnetic resonance (MR) imaging has not been the modality of choice 
to image the lung, due to the low density of hydrogen (H-1) nuclei in the lung tissue that 
results in a reduced low signal-to-noise ratio (SNR), and the numerous air-tissue interfaces 
that lead to susceptibility artifacts and hence poor image quality [2-4].  
In 1994, Albert et al. demonstrated the feasibility of using hyperpolarized (HP) gas 
as contrast agent to increase the MR signal from proton imaging [5]. The physical 
characteristics of Helium-3 (He-3) and Xenon-129 (Xe-129) make their use appealing for 
hyperpolarized gas imaging. They are the only stable, non-toxic and non-radioactive 
isotopes, with a nuclear spin of 1/2. Administered by inhalation, these MR contrast agents 
will fill the airspaces, allowing lung imaging [2-4].  
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1.2 Hyperpolarized Gas Imaging 
 
1.2.1 MR signal generation: polarization 
 
To better understand the need for polarization of He-3 and Xe-129, it is necessary 
to discuss the generation of the MR signal. The MR signal intensity (I) is proportional to: 
                                               (1) 
where P corresponds to spin polarization,    is the spin density,  the dipolar 
magnetic moment,   the flip-angle (FA),    the gyromagnetic ratio and B0 the main 
magnetic field.  
The polarization of spin-1/2 nuclei expresses the fraction of spins that are in the 
parallel state relative to the ones that are in the anti-parallel state with respect to the 
external magnetic field, before the excitation by the radiofrequency (RF) pulse. The ratio 
of this asymmetry dictates the strength of the MR signal and can also be given by: 
                                                                   
   
   
                                                    (2) 
in which kB represents the Boltzmann constant and T the absolute temperature. In 
proton MR imaging the polarization level is determined by the Boltzmann equilibrium with 
P = 5  10-6 reached at  = 1.411  10-26 Joules (J)/Tesla (T), B0 = 1.5 T, T = 310 Kelvin. 
However, the high H-1 spin density in most biological tissues (composed by water) 
Table 1 Current imaging modalities of interest in pulmonary drug research. Adapted from: [1]. 
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compensates for the low amount of polarization exhibited by hydrogen nuclei, yielding 
images with high SNR (Table 2).   
 
 
 
As discussed previously, in the case of lung imaging, the amount of lung tissue is 
reduced, so gaseous contrast agents are inhaled to improve the visualization of lung 
structures. However, even after the inhalation, the concentration of these gases is too small 
to generate a measurable signal. To overcome this problem, a large non-equilibrium 
polarization is achieved, in which the nuclear magnetic moments of the gas atoms are 
hyperpolarized above the Boltzmann equilibrium.  
 The optical pumping spin-exchange method, described in the next sub-section, is 
commonly used to polarize He-3 or Xe-129 gas and involves a transfer of angular 
momentum between an alkali-metal and the noble gases atoms. As a result, He-3 or Xe-
129 spins oriented anti-parallel to an external magnetic field are “pumped” to parallel 
states. The optical pumping metastability-exchange is another method used for 
hyperpolarization but, since is limited to He-3, it will not be described here [2-4]. 
 
1.2.1.1 Optical pumping spin-exchange polarization process 
 
In the optical pumping spin-exchange method, the polarization process occurs in 
two consecutive steps. The first involves the interaction of an alkali-metal vapor, usually 
rubidium (Rb), with a resonant laser light, which results in a change of its electronic spins 
from -1/2 to +1/2. Subsequently, the electronic polarization of Rb is transferred to the 
noble-gas nuclear spins through collisions between the atoms of both elements. The 
Table 2 MR characteristics of HP He-3 and HP Xe-129 compared with H-1. Adapted from: [2, 3]. 
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polarization transfer rate depends on Rb and noble-gas densities, laser power and 
temperature inside the glass cell, which can be adjusted for an optimized process [2-4].  
The glass cell that contains the gas mixture is kept under an external magnetic field, 
during the entire process. The presence of nitrogen (N2) is also required during the 
polarization of the noble gases for quenching the fluorescence of the excited alkali vapor 
atoms. In the case of Xe-129 polarization, natural helium (Helium-4) is added to the gas 
mixture to act as a buffer gas, increasing the pressure inside the glass cell [6, 7].  
At the end of the polarization process, the Rb vapor is condensed and the extraction 
of the hyperpolarized gases is done cryogenically. As HP Xe-129 has shorter relaxation 
times, because of the greater dimensions of the Xenon atom in comparison with the 
Helium atom, the Xe-129 gas is stored frozen, minimizing T1 (longitudinal relaxation time) 
decay, and thus reducing loss of polarization. This gas is solidified cryogenically, being 
separated from the N2 and Helium-4 gases (the solidification point of the noble gas is 
higher). When ready to be used, the Xe-129 ice is sublimated with hot water [6, 7].  
 
1.2.2 Sequence considerations and MR hardware prerequisites  
 
One important consideration to have in mind when imaging with HP gases is that 
there is no signal recovery, i.e., the non-equilibrium polarization is not renewable [2-4]. 
After excitation with the RF pulse, the spins return to the distribution predicted by 
Boltzmann statistics. The T1 signal decay is dictated by RF saturation and the paramagnetic 
effects of residual oxygen in the lung. Consequently, the longitudinal signal (Mz) decreases 
as function of the number of RF pulses (n) and the local partial pressure of oxygen (PO2).  
 
                                           
        
  
 
           
   
 
                                  (3) 
where M0 is the initial magnetization, TR the time to repetition,  the body 
temperature and  PO2 the relaxation rate due to local PO2. Note also the dependence of the 
signal decay rate with the FA. Spectroscopy and imaging pulse sequence with HP gases 
have to be designed in order to effectively use the available magnetization, being aware 
that after a 90º pulse there is no magnetization available. By Equation 3, we are able to 
conclude that the rapid pulse sequences with the adoption of low FA are necessary to 
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conserve the longitudinal magnetization. FA lower than 90º decrease the amount of 
magnetization tipped into the transverse plane, maximizing the magnetization used for 
signal generation.  
On the other hand, the nuclear magnetic moments of He-3 and Xe-129 are lower 
than that of H-1 (Table 2), leading to different Larmor precession frequencies. Thus, there 
are some necessary alterations regarding the equipment that should be taken into account. 
For instance, a broadband RF system is needed for transmission, reception and 
amplification of the signals, as well as a purpose-built RF coil tunable to the appropriate 
frequency.  
As regards to principal magnetic field strength, the initial magnetization depends 
linearly on the gyromagnetic ratio but not on B0, so the magnetization available is 
independent of the field strength of the scanner (Equation 3). To this date, most studies 
have been performed in 1.5 T scanners, as artifacts have been reported when using higher 
field strengths [3, 8].  
 
1.3 Hyperpolarized He-3 versus Hyperpolarized Xe-129 
 
The use of He-3 for human lung imaging has been facilitated by its large 
gyromagnetic ratio, and achievable polarizations of 40% or greater (Table 2), providing 
high signal strengths [2-4]. There are various results in both animals and humans that 
demonstrate the potential of this gas in lung imaging [2-4, 9, 10]. Nevertheless, one major 
disadvantage can be pointed out regarding the use of He-3 that opens new possibilities for 
Xe-129. Since He-3 is obtained from tritium decay mainly occurring in the production of 
nuclear weapons, the world’s stock is limited. Recently, the demands of this gas for 
homeland security purposes have increased the prices as the worldwide supply is 
diminishing, preventing its widespread use in the clinical setting.  
Although the use of Xe-129 has been restricted by its low gyromagnetic ratio, 
which results in lower SNR, the advances in the polarization level, nearing 50% at large 
output volumes [6, 7], have made it possible for Xe-129 to be eligible for lung imaging 
(Table 2). On the other hand, its unlimited supply, as constituent of earth’s atmosphere, 
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and the relatively low-cost of enriched Xe-129 have made its use much more affordable 
than He-3 [2, 3]. 
However, the most appealing feature for using Xe-129 is the solubility in lipid and 
water-containing tissues (Table 2), which allows this gas to easily diffuse through cell 
membranes [11-16]. The majority of Xe-129, when inhaled, exists as gas in the alveoli (gas 
phase) while a small fraction (~1 to 2%) is dissolved in the lung parenchyma (tissue) or in 
the red blood cells (RBC) [4, 16]. As the resonance frequency of Xe-129 is strongly 
influenced by its medium, a chemical shift occurs for this gas in different lung 
compartments: the frequencies of Xe-129 dissolved into the lung parenchyma and the RBC 
are shifted by about 200 parts por million (ppm) from the frequency of Xe-129 as gas, 
becoming possible to differentiate the gas- and dissolved-phases using spectroscopy [4, 14, 
16]. For these reasons, it is expected that techniques that use Xe-129 gas will provide 
valuable insights into pulmonary uptake-exchange processes, essential for the evaluation 
and staging of pulmonary disease progression. 
 
1.4 Xe-129 spectroscopy studies: measuring gas uptake-exchange in the lungs 
 
The uptake-exchange of alveolar gases consists of two consecutively ordered 
components. The first is associated with the diffusion of the gas through a semi-permeable 
membrane, which constitutes the air-blood barrier, and is determined by thickness and 
surface-area of the membrane and the second component is related to hemoglobin-binding 
gases such as oxygen and carbon dioxide,  and depends on the reaction rate with the blood 
volume.  
The total thickness of the air-blood barrier is only a fraction of 1 micrometer (m). 
Considering an average diffusion constant in tissue on the order of 2  10-5 square 
centimeters (cm
2
)/second (s), xenon would equilibrate with the lung parenchyma and the 
blood within tens of milliseconds (ms) [13]. Therefore, this diffusion time is expected to be 
highly sensitive to certain pathological conditions (Figure 1). Any increase in this time 
period could indicate thickening of the pulmonary membranes, as occurs in certain lung 
pathologies, such as cystic fibrosis. 
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The uptake of alveolar gases or diffusion capacity is commonly measured using 
carbon monoxide (DLCO), which is the primary mean of directly assessing gas uptake and 
diagnosing pathologies that might affect the gas exchange. Unfortunately, DLCO only 
provides a global measurement of gas uptake and cannot present heterogeneity caused by 
disease [12]. Alternatively, the diffusing capacity can be indirectly estimated by imaging 
techniques that provide regional information about this parameter. As mentioned before, 
HP Xe-129 has been presented as a great candidate for, non-invasively probing gas 
exchange-uptake through MR spectroscopy [11-16].  
Depending on the resolution and the time available for the xenon to dissolve, 
spectroscopy using this gas generates a spectrum with three distinct peaks, each one 
associated with Xe-129 in a different physiological compartment. Gaseous Xe-129 in the 
major airways, bronchioles and alveolar spaces originates a peak at 0 ppm and is usually 
used as a reference. Two broad  and partially overlapping peaks are also observed at 
around 198 ppm and 218 ppm, arising from Xe-129 dissolved in lung tissue and bound to 
hemoglobin inside the RBC, respectively (Figure 2) [12, 16].  
High-quality images of the dissolved-phase are extremely difficult to obtain 
because only a small fraction of gas (~1 to 2%) gets dissolved in the lung parenchyma or in 
the RBC at a certain time [4, 16]. As a result, the gas signal has a large component in the 
MR spectrum, even with a narrow-band RF pulse centered at the frequency of the 
dissolved-phase peaks (Figure 2).  
 
 
Figure 1 Depiction of the alveolar-capillary unit (A) and corresponding Xe-129 spectroscopy signal in arbitrary units (AU) 
from the tissue (B) and RBC (C) for barrier thicknesses ranging from 1-7.5 m and constant capillary diameter (8 m). 
The detection of the RBC signal is delayed as barrier thickness increases. Adapted from: [11]. 
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Regarding spectroscopy measurements done to characterize the Xe-129 gas uptake 
and exchange in the lungs, three techniques are worth to mention. 
Swanson et al. in 1999 directly imaged Xe-129 in the dissolved phase of the rat’s 
lung by using chemical shift imaging (CSI) [17]. However, the resulting maps were just a 
rough presentation of the animal’s lungs due to the large voxel size (poor resolution) and 
low gas polarization (~5%). Also, this previous implementation of CSI required multiple 
breath-holds, mechanical ventilation and imaging for 8 minutes, which is not feasible for 
clinical applications. 
 
 
 
 
 
 
 
 
 
 
An alternative imaging method retains higher spatial resolution while probing the 
gas exchange processes and is termed xenon polarization transfer contrast (XTC) [13-15]. 
This method is based on the attenuation of Xe-129 in the airspace after RF irradiation of 
the dissolved phase to map Xenon exchange between gas- and dissolved-phases. The 
magnetization of the dissolved-phase is saturated in the way that a permanent label is 
applied and the atoms cannot return to unlabeled state through relaxation. The only way to 
restore the unlabeled state is by the exchange through diffusion with the unlabeled atoms 
from the gas phase, decreasing the gas-phase magnetization. The main disadvantage of this 
technique is that it does not distinguish Xe-129 signals originating from different 
dissolved-phase compartments.  
Another method was demonstrated by Driehuys et al. to overcome this problem, 
known as Xenon Alveolar Capillary Transfer (XACT) [11]. This method is based on the 
Figure 2 Representative Xe-129 spectrum from a human lung, showing peaks at 0, 198 and 218 ppm, which correspond to 
xenon in the airspaces, dissolved in the lung parenchyma and the red-blood cells. Note that the relative sizes of the spectral 
peaks, in arbitrary units (AU), do not reflect the actual Xe-129 distribution, since only about 1 to 2% of all the gas is in the 
dissolved-phase at any given time. The RF pulse is applied at the dissolved-phase frequency, having a FA that is 
maximum at this frequency, while the gas-phase experiences a FA less than 1º. Adapted from: [16]. 
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Dixon imaging technique, developed to separate water from fat containing tissues in MR 
images. The XACT takes advantage of the difference in resonance frequency of the gas 
dissolved in the tissue and in RBC to image them at a specific phase shift. However, this 
technique cannot distinguish the signals from different lung compartments in a single 
breath inhalation.  
The method demonstrated in this work and pioneered by the group at the 
Department of Radiology and Medical Imaging of the University of Virginia  is the first 
capable of obtaining three dimensional (3D) characterization of gas distribution and 
uptake-exchange into the lung parenchyma and the red-blood cells, separately and in a 
single breath-hold. This technique combines the use of CSI and HP Xe-129, having 
sufficient resolution to detect defects in all lung compartments and is denominated 3D 
Single Breath-hold Chemical Shift Imaging [18-21]. 
 
1.4.1 3D Single Breath-hold Chemical Shift Imaging  
 
The pulse sequence employed in the 3D SB-CSI technique was created by 
modification of a standard CSI pulse, allowing it to be used with HP Xe-129.  
Atomic nuclei are surrounded by electrons that can shield the magnetic field, 
reducing the net magnetic field experienced by nuclear spins. Therefore, protons in 
different microscopic environments resonate at slightly different frequencies as a result of 
this shielding. The frequency separation (fcs) between protons from different surroundings 
is obtained by: 
 
                                               
   
  
                                                           (4) 
 
where  is the chemical shift in ppm.  
A plot of the MR signal intensity of a certain object versus the chemical shift 
constitutes a spectrum. RF pulses that are designed to selectively excite or invert certain 
regions in the spectrum are denominated spectrally selective pulses. Every RF pulse has a 
corresponding frequency response, which can be calculated by solving the Bloch equations 
[22]. For example, a cardinal sine (SINC) function RF pulse yields a rectangular frequency 
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response.  For a given pulse shape, the width of the frequency response (i.e. bandwidth in 
Hertz - Hz) is inversely proportional to the RF pulse width (in ms). Applied simultaneously 
with a gradient, the frequency response of an RF pulse is converted to a spatial profile, 
whereas without a gradient, the frequency response originates a single spectral profile. For 
spins whose resonance frequency is inside the profile, the pulse plays its designed 
functions. Outside the profile, the pulse has no effect on the spins. 
The Single Breath-hold Chemical Shift Imaging (SB-CSI) technique exploits the 
fact that, once inhaled, HP Xe-129 dissolves in the lung parenchyma while diffusing and 
binding to hemoglobin, inside the RBC. Once dissolved, Xe-129 produces distinct MR 
signals (“peaks”) that are shifted in resonant frequency from the main gaseous Xe-129 
peak. Thus, the relative amount of Xe-129 in each compartment (in RBC, tissue, or 
alveolar airspaces) can be deduced from the frequency and integral of its peak. 
In order to create a CSI pulse sequence with high-resolution and an acquisition time 
in the same order as a breath-hold, the entire pulse sequence had to be redesigned.  
Since there is no recovery of the longitudinal magnetization after excitation by the 
RF pulse, the TR of the pulse sequence could be reduced to a minimum, limited only by 
the HP Xe-129 diffusion rate between the alveoli, parenchyma and RBC. This allows the 
same number of voxels to be acquired in shorter acquisition times. A further compaction of 
the pulse sequence could also be achieved by reducing the time of the spoiling/dephasing 
gradients at the end of each TR (Figure 3). Concurrently, the amplitude of the same 
gradients is increased, resulting in an identical net area, so that the initial dephasing effect 
is retained.   
To optimize the use of the available HP Xe-129 signal, other approaches were 
implemented.  
Since the transverse relaxation time that accounts for field inhomogeneities (T2*) 
of dissolved HP Xe-129 is short, 1.5 to 2.4 ms at 1.5 T [12], echo time (TE) had to be 
reduced to less than 2.4 ms, thus minimizing signal loss due to decreasing levels of 
transverse magnetization.  
A RF flip-angle of less than 30º per voxel was also chosen, instead of the traditional 
more than 30º used in this type of sequence [23]. A low FA permits maximizing the 
magnetization available for signal generation, since a smaller amount of longitudinal 
magnetization is tipped into the transverse plane. For each excitation, an RF pulse with 
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bandwidth 3125 Hz, which corresponds approximately to the frequency separation of gas 
and dissolved-phases, and duration 1280 microseconds (s), was applied at the frequency 
of the Xe-129 in the dissolved-phase. This frequency is at, approximately, 200 ppm from 
that of HP Xe-129 gas in the airspaces [4, 14, 16].  
The modifications described above permit scan times of less than 15 s, which is an 
important feature for imaging patients with pulmonary disease that cannot hold their breath 
for larger periods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Pulse sequence diagram for SB-
CSI sequence. Note the compaction of all 
gradients to reduce TE and TR.  
GZ
GX
GY
ADC
RF
N = # voxels
N = # voxels
Readout
Figure 3 Pulse sequence diagram for the 3D SB-CSI techniqu . A SINC RF pulse is used to excite the Xe-129 spins, while a 
slice selection gradient is applied in the z-plane (Gz). In the x- and y- planes are applied the phase and frequency encoding 
gradients (Gx and Gy) and then the transverse magnetization is measured by receive coils.  At the end of each readout, 
spoiler gradients are added in all planes to eliminate all unwanted transverse magnetization before the next RF pulse. 
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Chapter II: 
Clinical application of 3D SB-CSI: cystic fibrosis 
 
 
2.1 About Cystic fibrosis  
 
Cystic fibrosis (CF) is the most common, fatal, inherited disease in the Caucasian 
population. CF is caused by a mutation in the gene responsible for production of the 
protein cystic fibrosis transmembrane conductance regulator (CFTR), required to regulate 
the components of sweat, digestive juices, and mucus. Usually, mutations in the CFTR 
gene lead to abnormal transport of chloride ions across the airway epithelium, causing the 
production of unusually thick and viscous mucus. Instead of serving as a lubricant, the 
mucus clogs the airways, impairing lung ventilation and creating an ideal breeding ground 
for chronic airway infections. Permanent lung damage might include formation of scar 
tissue (fibrosis) and cysts. The thick mucus also obstructs the pancreas, preventing 
enzymes from reaching the 
intestines to digest food [24, 25].  
It is estimated that about 
70,000 children and young adults 
have been diagnosed with CF 
worldwide, with 30,000 cases only 
in the United States. This disorder is 
typically diagnosed in early infancy 
by a sweat test or before birth by 
genetic testing [25].  
Due to the advances in 
clinical care and medical research of 
the past decades, the life expectancy of CF patients has increased substantially (Figure 4), 
being the current median age of survival in the late 30s [24, 25]. Although cystic fibrosis is 
not yet curable, clinical studies to test the potential of a variety of treatments have been 
Figure 4 Average life expectancy (in years) in cystic fibrosis 
throughout the years. The development of new treatment options has 
resulted in improved survival of patients, being the current median age 
of survival in the late 30s. Adapted from: [25]. 
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performed, many of them focused on therapeutic anti-inflammatory strategies [25, 26]. 
Clinical trials of a new drug therapy approved by the Food and Drug Administration in 
January 2012, Kalydeco
TM
, (Ivacaftor, Vertex, United States), which is classified as a 
CFTR potentiator, showed promising preliminary results. This new drug is indicated for 
the treatment of CF in patients 6 years of age and older who have a specific mutation in the 
CFTR gene [25, 27]. In extreme situations, lung transplantation may be considered when 
lung function is reduced to the point where assistance from mechanical devices is required 
for patient survival [25]. 
 
2.2 Cystic fibrosis: diagnosis and monitoring 
 
Monitoring of disease progression and efficacy of treatments plays an important 
role in improving the prognosis in CF. A decrease in the pulmonary function test parameter 
forced expiratory volume in one second (FEV1) was shown to be the best prognostic factor 
for the course of the disease and the most significant predictor of mortality in a study done 
with CF patients [28, 29]. However, pulmonary 
function tests give no regional information 
about lung morphology or function, providing 
only a global assessment of ventilation 
parameters, which can mask focal disease and 
regional changes with treatment. Moreover, this 
method is highly dependable on patient effort 
and collaboration, being difficult to perform in    
young children [26, 28]. 
The morphological features of CF have 
been described in several studies [24, 28, 30]. 
Extensive inflammation of the bronchial walls 
was found in CF lungs when compared to 
controls [24, 28, 30]. Other structural changes of 
CF disease include bronchiectasis (destruction and widening of the airways), mucus 
plugging, consolidation and segmental-lobar destruction (Figure 5) [24, 28].  
Figure 5 Axial computed tomographic image of the 
lungs of a 14-year-old girl with cystic fibrosis, 
demonstrating some of the morphological features 
of the disease (white arrows), such as bronchial wall 
thickening, bronchiectasis, peripheral mucus 
plugging and dorsal consolidations. Adapted from: 
[28]. 
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Of the imaging techniques used for probing the morphological changes of the 
airways and the lung parenchyma, chest x-ray is the most widely used modality. However, 
x-ray is not ideal for early assessments of the disease since it has limited sensitivity. CT 
has emerged as “the gold standard” to monitor the morphological changes related with CF 
and so far, it is the only reliable imaging method capable of monitoring early stages of CF 
lung disease [24].  
Although CT is able to provide high temporal and spatial resolutions of the lung 
parenchyma, it exposes the patient to relatively high doses of ionizing radiation. This is an 
extremely undesirable feature considering the need for repeated assessments in pediatric 
patients, who are more sensitive to the carcinogenic properties of ionizing radiation. On the 
other hand, HP Xe-129 MR imaging allows high-resolution imaging, providing a way to 
evaluate regional lung function, without the risks associated with repeated exposure to 
ionizing radiation.  
A better understanding of pulmonary disease progression, including the associated 
genetic and molecular pathways, is desirable. Currently, no imaging technique, suitable for 
clinical application, is able to provide a measurement of one of the most basic 
physiological lung functions that is the gas uptake-exchange in lung tissue and blood [16]. 
The implementation of the 3D SB-CSI technique aims to distinguish the physiological 
alterations that may occur at the ventilation, tissue structure or blood flow levels. This 
knowledge may allow for an earlier forecast of treatment responses and outcomes, as well 
as for the identification and correlation of physiologic alterations based on different genetic 
types of CF.     
 
2.3 Materials and Methods 
 
2.3.1 Subject characteristics 
 
Nine independent clinical studies were performed in seven volunteers enrolled in 
this study (Table 3): 3 healthy (mean age: 19 years-old), 3 CF-previously diagnosed (mean 
age: 27 years-old) and 1 subject with high second-hand smoking exposure; one healthy and 
one CF were imaged twice for a repeatability study. All subjects were submitted to a 
baseline spirometry examination, including measurement of FEV1 and forced vital capacity 
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(FVC), prior to the MR scan to determine eligibility and disease category. Subjects with 
FEV1 > 50% and FEV1 < 70% were considered in the moderate-CF category, and subjects 
with FEV1  70% in the mild category. Healthy subjects had normal spirometry values 
(FEV1  80% and FEV1/FVC  0.70) and no history of pulmonary disease.  
All studies were supervised by a physician and the subject’s heart rate and oxygen 
saturation levels were monitored throughout the MR session. All subjects were able to 
inhale HP Xe-129 and hold their breath for the scan duration. No relevant side effects were 
experienced by any of the volunteers, besides instant euphoria and a decrease in blood PO2. 
 
2.3.2 Polarization  
 
Isotopically enriched (~87%) Xe-129 was polarized via optical-pumping spin-
exchange to approximately 35 to 50% using a commercial prototype system (Xemed LLC, 
United States).  
To overcome the low gyromagnetic ratio of Xe-129 (of almost three times lower 
than the gyromagnetic ratio of He-3) and provide an elevated image SNR, high 
polarization levels must be achieved.  
The Xemed polarizer (Figure 6) used in this study is the only one capable of 
reaching polarization levels of 50% with high output volumes, as a result of some design 
modifications [6, 7].   
A spiral trajectory is used for the glass cell, in order to increase the volume of Rb 
vapor polarized by the laser. This strategy is also employed when the Xe-129 ice is 
sublimated, achieving a more efficient process by increasing the surface-to-volume ratio of 
Table 3 Subject data. 
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the ice in contact with hot water. Moreover, oil is used to heat the glass cell, instead of 
high pressure air, permitting less variation of temperature. With these improvements and 
the application of 1200 Watts of laser power, the Xemed polarizer is able to polarize 2 
Liters (L) of Xe-129 with high polarization levels (35 to 50%) in 15 minutes. Prior to the 
MR scans, HP Xe-129 was dispensed into Tedlar bags and transported to the MR scanner 
across the hallway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.3 MR scans 
 
All scans were done in a 1.5 T clinical system (Avanto, Siemens Medical Solutions, 
United States) using a linear transmit/receive RF coil built in-house and tuned to the Xe-
129 frequency.  The subjects were positioned supine on the MR table with the chest coil 
strapped around their chest and placed into the scanner at the isocenter. A set of 3D proton 
scout localizer MR images were obtained to confirm the position of the lungs at the 
isocenter and to determine positioning of the Xe-129 acquisitions. The volume of gas 
administered to the subjects depended on their FVC values; for each acquisition, 700 to 
900 milliliters (mL) of HP Xe-129 gas, mixed with room air or oxygen (230 to 500mL), 
Figure 6 Xemed polarizer used in the Xe-129 studies performed at the Department of Radiology and Medical Imaging 
of the University of Virginia. 
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was inhaled by the subjects, followed by a breath-hold during the entire pulse-sequence 
acquisition. A matrix of 18x18x8 voxels, interpolated to 32x32x8 voxels, was positioned 
over the lungs, with a field-of-view of 320x320 to 350x350 square millimeters (mm
2
), 
corresponding to an in-plane resolution of 17.8x17.8 to 19.4x19.4 mm
2
. The slice thickness 
varied from 25 to 31.25 millimeters (mm), TR was 27 ms and TE was 2.3 ms.  
 
2.3.4 Spectroscopy data: signal processing 
 
Xe-129 CSI post-processing was performed using the 3DiCSI (Qi Zhao, Columbia 
University, United States) software package.  
In MR spectroscopy, the resulting data from the MR measurements, also known as 
free-induction decay (FID) response signal, is presented in the time-domain. In order to 
obtain the conventional spectrum, i.e., a frequency-domain signal, the data has to be 
Fourier Transformed. If the FID is obtained in a complex form, as occurs in this case, the 
Fourier transformation will give a complex frequency-domain signal, that is, composed by 
real and imaginary parts. The real part of the spectrum contains a peak with the absorption 
mode with a Lorentzian lineshape, whereas the imaginary part represents the dispersion 
mode, also with Lorentzian lineshape (Figure 7). The FID has also an arbitrary phase 
associated with it and the relative contributions of absorption and dispersion lineshape 
depend on the phase, i.e., the real part of the spectrum, and likewise for the imaginary part, 
may contain a mixture of absorption and dispersion modes (Figure 8) [31-33]. 
 
 
 
 
 
 
 
Figure 7 Fourier transform of an exponentially decaying time-domain signal yields a spectrum, whose real and imaginary 
parts have the absorption and dispersion mode Lorentzian shapes, respectively. The arrows represent the width at half 
length. Adapted from: [32]. 
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In this case, it is necessary to make sure that the real part of the spectrum has the 
absorption mode lineshape as this corresponds to the narrowest peaks. Thus, to obtain a 
pure absorption mode, the phase must be corrected.  
 
 
 
 
 
 
 
 
 
 
 
A constant phase correction is applied to the whole spectrum. However, in some 
cases the phase is not the same for all the peaks in the spectrum, varying from one edge to 
the other. One of the reasons for this to happen is attributable to the design of the RF pulse. 
This off-resonance effect can be corrected by introducing a factor that multiplied by the 
spectrum gives a phase correction proportional to the offset [31-33].   
As mentioned before, the key aspect of the 3D SB-CSI technique is that it is able to 
separate the dissolved-phase peaks. For that, it may be necessary to obtain a better defined 
spectrum and one way to do it is through a post-processing method termed zero filling. The 
original FID is added an equal amount of zeros, so that the spectrum will have the double 
of its original length.  
On the other hand, adding more points to the spectrum might result in increased 
noise, and consequently reduced SNR. Noise is classically described as ‘Gaussian with 
zero mean’, which means that the time average of the noise is zero and the probability of a 
certain amplitude to occur is proportional to a Gaussian function of the amplitude, that is, 
high amplitude spikes are less probable to occur than small amplitude spikes. The Fourier 
Transform does not alter the features of the noise: it retains both the Gaussian distribution 
Figure 8 Depiction of the effect of a phase shift on the spectrum. The corresponding x- and y- components of the time-
domain signal are shown, as well as the real and imaginary parts of the spectrum. Depending on the phase of the signal, 
the real and the imaginary parts may contain an absorption or dispersion mode lineshapes or a mixture of both. Adapted 
from: [33]. 
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and the zero mean. It is also important to consider that a typical time domain signal has 
higher amplitude at the beginning, decaying over time, while the noise remains constant 
throughout. This suggests that the early fraction of the time-domain signal contains the 
most significant information of the signal. Thus, the later parts of the signal can be 
attenuated by multiplying the time-domain signal by a decaying weighting function. A 
common choice for a decaying function is a Lorentzian (only the right-hand half of the 
curve, i.e., time > 0). The decay rate of the filter must be chosen considering that the noise 
will not be attenuated significantly with slow rates, and fast rates may result in a reduction 
of peak height, thus leading to degradation of the SNR.  
In Figure 9, the effects of the post-processing methods mentioned above are 
depicted in a spectrum corresponding to a pixel from a subject imaged through the 3D SB-
CSI technique.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 Representation of the post-processing methods used in this study, applied in the real part of a selected spectrum of a 
voxel of one of the subjects’ lungs. (A) Spectrum without any treatment, showing dephasation of both gas and dissolved-
phase peaks. (B) Spectrum with frequency dependent phase correction, resulting in absorption mode with a Lorentzian 
lineshape peaks. (C) Spectrum with phase correction, one time zero filling and a 50 Hz Lorentzian filter. As the RF pulse was 
applied at the dissolved-phase frequency, the software program uses that frequency as reference, so the gas peak is at around 
200 ppm not 0 ppm, as usually represented. The amplitude is represented in arbitrary units (AU). 
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As mentioned before, some spectra exhibit a frequency dependent offset and thus a 
frequency dependent phase correction is required to obtain an absorption mode with a 
Lorentzian lineshape for all the peaks (Figure 9B). By comparing the phase corrected 
spectrum (Figure 9B) with the one combining zero filling and filtering with a 50 Hz 
Lorentzian decaying function (Figure 9C), we are able to notice that the latter is better 
defined, which is a desirable feature for determining peak intervals correctly. The decay 
rate was chosen in a way that the amplitude of the peaks was not significantly reduced, 
while maximizing noise attenuation.  
Having in mind the considerations stated above, the time-domain data (FID) of 
each pixel from each slice was zero filled to 1024 points, filtered with a 50 Hz Lorentzian 
decaying function, Fourier Transformed and the real part corrected for phase shifts. 
Furthermore, the phase offset was not constant throughout the lungs, thus a phase 
correction had to be done manually for each outlier voxel of the lung. This heterogeneous 
dephasation effect might be related to multiple effects like: magnetic field 
inhomogeneities, movement of the heart and vibration of the diaphragm in the thoracic 
cavity or the RF pulse design. These effects will be addressed in the conclusion section. 
 
2.3.5 Spectroscopy data: map generation and quantification 
 
2.3.5.1 Map generation 
 
In the majority of spectroscopy 
studies, the real part of the signal is used 
for quantifying the data, mostly because it 
corresponds to the narrowest peaks [31]. 
However, in circumstances where the phase 
correction is challenging, as in this case in 
which the phase shift is not uniform 
throughout the lung, the absolute signal can 
be used. The absolute signal has a 
contribution of both real and imaginary parts 
Figure 10 Absolute of the spectrum represented in 
Figure 9C, revealing the broadening of all peaks. The 
amplitude is represented in arbitrary units (AU). 
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and is phase independent, which results in broader peaks, as shown in Figure 10.  
All maps depicted in Figures 11A and B were generated through area integration, 
i.e, the area under the curve is calculated considering a given interval. Corresponding 
ventilation, tissue and RBC maps created using the absolute signal (Figure 11B) are 
smoother and have better quality than the ones generated with the real part (Figure 11A). 
It is also possible to note that the dissolved phase maps (tissue and RBC) appear 
identical, perhaps due to signal contamination from their very close spectral proximity at 
this magnetic field strength. Thus, Principal Component Analysis (PCA) was also applied 
to the real part of the signal in an attempt to obtain more distinction between the signals 
from the tissue and the RBC (Figure 11C). The aim of PCA is to reduce the quantity of 
spectral data, and thereby avoid overfitting, without discarding any useful information. 
PCA uses projections to extract from a greater number of variables, a much smaller 
number of new variables. Each of the new variables (principal components) is a linear 
combination of the original measurements and therefore contains information from the 
entire selected spectrum. In this case, the amplitude of the principal component with higher 
eigenvalue value (fraction of total variation of the data set that the principal component 
explains) is measured and displayed on a map [34]. However, the use of PCA did not 
appear to make a significant difference in separating the signals from the dissolved phase 
or increasing image quality. For this reason, area integration of the absolute signal was 
chosen for map generation.    
In sum, ventilation, tissue and RBC maps were obtained calculating the area under 
the absolute peaks with the software package referenced in the previous section. Frequency 
shifts were observed in some subjects. However, the interval size of area integration of 
each peak was chosen to be constant among every slice of each subject and between 
subjects. Care was taken to cover as much of the peak data points as possible, while 
minimizing noise inclusion. In some cases, position of the inflexion point between the 
dissolved-phase peaks also changed in frequency throughout the lung. In these cases, a 
recurrent position was chosen.  
The chemical shift of the dissolved-phase peaks in all subjects remained relatively 
invariable, being of 198±1.0 ppm and 214±1.4 ppm, for the tissue and RBC peaks, 
respectively. These values are in close agreement with the ones presented in section 1.2.4 
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and in [12, 16]. To improve image quality, the data was interpolated from a matrix of 
32x32 to 128x128 voxels. 
 
 
 
 
 
 
 
 
 
 
 
2.3.5.2 Map quantification 
 
One of aims of this study was to find a quantification method capable of 
differentiating healthy from CF subjects. Area integration of a single peak does not provide 
meaningful information about physiological function that can be compared among 
subjects, regardless of the amount of gas inhaled and polarization level. The ratio of Xe-
129 in the dissolved-phase to that in the gas-phase is commonly chosen as a normalization 
method [16]. However, with the data collected for this study, the normalized tissue and 
RBC ratios did not appear to be directly correlated with disease. The use of slightly 
different FA profiles might be a reasonable explanation for the variability in the amplitude 
of the dissolved-phase peaks relative to the gas peak among subjects of the same health 
status. Gas uptake and exchange in lung tissue and RBC can also be assessed by obtaining 
the ratio of gas dissolved in the tissue to that dissolved in the RBC. This will allow 
inferring about pulmonary membrane thickness, which can be increased in case of CF 
disease.  
Figure 11 Coronal Xe-129 CSI maps of a healthy subject’s lungs central slice.  Xe-129 in alveoli (ventilation), dissolved 
in tissue and in RBC maps, generated through (A) area integration of the real part of post-processed signal, (B) area 
integration of the absolute signal and (C) PCA of the real part of the spectrum. The contrast and brightness were 
maintained within maps corresponding to the same lung compartment. 
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On the other hand, using the absolute part of the signal has also proven to be 
inefficient in distinguishing healthy from CF subjects. RBC peak broadening, observed in 
the absolute spectrum (Figure 10) and demonstrated by the higher intensities in the 
absolute RBC map (Figure 11B) compared to the corresponding map generated with the 
real part (Figure 11A), might be one of the reasons for this lack of distinction between 
subjects. As expected, as the RBC peak broadens, the quantification becomes less sensitive 
to minor deviations. Consequently, the data was quantified using the real part of the signal.  
In short, 32x32 voxels maps of the ratio of Xe-129 dissolved in tissue to Xe-129 
dissolved in RBC (tissue/RBC) were generated for the masked lung regions (to avoid the 
inclusion of noise), through area integration of the real part of the spectrum. This was 
performed for each slice of each subject using the same software package. Only coronal 
slices were quantified, since they are the most commonly chosen to evaluate respiratory 
physiology. The mean, median and standard deviation of each slice were calculated. 
 
2.4 Results 
 
With the 3D SB-CSI technique, three dimensional regional information of 
ventilation and gas uptake-exchange into different lung compartments was obtained, 
through acquisition of multiple-slices and multiple-planes, in order to cover the whole 
lung. Examples of the acquisition of multiple-slices are given in Figures 12A and B for a 
healthy (subject 1) and a moderate-CF subjects (subject 5), respectively, while multiple-
planes of the Second-Hand Smoker (SHS) subject’s lungs (subject 4) are depicted in 
Figure 12C. 
In the next sections, the results of CSI map generation and quantification will be 
presented for healthy and CF subjects. The case of the SHS will also be analyzed in section 
2.4.2.  
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2.4.1 Healthy versus Cystic fibrosis subjects 
 
2.4.1.1 Map generation 
 
Xe-129 maps of the gas in the alveoli (ventilation) as well as dissolved in the lung 
tissue and in RBC demonstrated that healthy subjects presented homogenous ventilation 
and gas uptake-exchange within the lung. (Figure 12A).   
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Figure 12 3D SB-CSI acquisition of the whole lung. Coronal CSI maps of Xe-129 as gas in alveoli (ventilation) and 
dissolved in tissue and in RBC in (A) a healthy subject (subject 1), and (B) a subject with moderate cystic fibrosis 
(subject 5). Ventilation images of Xe-129 using a gradient echo (GRE) pulse sequence (A: TR 6.8 ms, TE 1.6 ms and in-
plane resolution 4.4x4.4 mm2; B: TR 6.0 ms, TE 0.6 ms and in-plane resolution 7.5x7.5 mm2) were matched slice by slice 
to CSI maps. Note the signal originated from the heart in the most anterior slices in the dissolved-phase maps and its 
absence in the ventilation maps. (C) Coronal, axial and sagittal views of the SHS’s lungs (subject 4; tissue maps) 
obtained in a single breath hold. Contrast and brightness were maintained within maps corresponding to the same lung 
compartment. 
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On the other hand, multiple regional defects (small areas with less or no detectable 
signal) could be observed in the CF subjects (Figures 12B and 13) in all three lung 
compartments, showing impaired ventilation, and consequently heterogeneous gas uptake 
by lung tissue and blood.  
Increased ventilation, tissue density and perfusion were most visible in central-
posterior slices of healthy subjects, as indicated by the higher signal intensities (Figure 
12A).  
Contrarily, tissue and RBC maps of the moderate-CF subject did not exhibit the 
same trend, as signal intensity did not seem to change significantly towards the posterior 
regions of the lung (Figure 12B).  
Both healthy and CF subjects CSI ventilation maps presented in Figures 12A and B 
correlated well with direct MR ventilation images using traditional HP Xe-129 MR 
imaging techniques (GRE Xe-129 Ventilation).  
The effect of different degrees of disease severity was also assessed by comparing 
the amount of defects in the maps of each lung compartment. As demonstrated in Figure 
13, the moderate-CF subject (subject 5) showed whole lung heterogeneity, while the mild-
CF subjects (subjects 6 and 7) only presented impaired ventilation and gas uptake-
exchange in the superior portion of the lung. The very-mild CF subject (subject 7) had the 
fewest defects in the lungs, which correlated well with the predicted FEV1 that is situated 
in the normal range. 
 
 
 
 
 
 
 
 
 
 
Figure 13 Coronal Xe-129 ventilation and dissolved-phase maps of a central lung slice of all cystic fibrosis subjects 
included in this study, with respective predicted FEV1 values (FEV1 pred.). The amount of defects in all lung 
compartments correlated well with the spirometry values. 
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The CSI maps presented here also showed that the tissue and RBC maps may 
provide additional information regarding lung physiology that cannot be deduced from the 
ventilation maps. Not only the dissolved-phase maps showed areas of the lungs with signal 
that may not be ventilated, signal from dissolved Xe-129 also appeared beyond lung tissue, 
for instance in the myocardium and blood inside the heart cavities. In Figures 12A and 14, 
those structures were seen in tissue and RBC maps and not in the ventilation map. 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.1.2 Map quantification 
 
The regional information presented on the tissue/RBC ratio maps shows a relatively 
homogenous distribution of the Xe-129 dissolved in tissue to Xe-129 dissolved in RBC in 
the healthy subjects (Figure 15A).  
Conversely, in the CF subjects’ maps, it was possible to observe focal elevations of 
this ratio, accompanied by a higher standard deviation value (STD) (Figure 15B). Most 
importantly, a median increase in the tissue/RBC ratio was detected in all slices, also 
noticeable by the existence of warmer colors in the maps. The median of the signal-
containing voxels of the lungs was the statistical measure chosen to represent the data in 
order to minimize the influence of outliers in the distribution. 
 
 
Figure 14 Coronal Xe-129 maps of all lung compartments in a plane that 
contained the heart (most anterior). The myocardium and blood inside the heart 
cavities were seen in the dissolved-phase maps, but not in the ventilation map. 
The white arrow, in the ventilation map, refers to the artifact caused by the 
vibration of the diaphragm due to the RF pulse. 
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The ratios of the Xe-129 dissolved in tissue to that dissolved in the RBC for each 
slice of each subject as well as the mean ratios for each subject are depicted in Figure 16.  
Subjects with the lowest predicted FEV1 values (FEV1 predicted of 55% and 71%) 
showed higher mean tissue/RBC ratio values (3.0±0.36, 3.4±0.16 and 3.1±0.34) in 
comparison with the healthy subjects (overall mean of 2.4±0.22), with mean percentage 
differences of 25%, 42% and 29%.  
The very mild-CF subject (FEV1 predicted of 87%) presented a tissue/RBC ratio of 
2.7±0.27, which is close to the healthy range. This result showed good agreement with the 
spirometry values, since they indicated an almost normal pulmonary function.   
 
 
 
 
 
 
 
Figure 15 Coronal tissue/RBC ratio maps of a (A) healthy subject (subject 3) and (B) cystic fibrosis subject (subject 6) 
with respective median and standard deviation (STD) values. The CF subject presents a higher median and STD values 
for all slices in comparison with the healthy subject. 
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For the two performed repeatability studies, the difference of the mean tissue/RBC 
ratios between the two consecutive acquisitions of the same subject was 10.5% for the CF 
subject (subject 6; FEV1 predicted of 71%), and 3.9% for the healthy subject (subject 3; 
FEV1 predicted of 88%). 
 
2.4.2 Second-Hand Smoker subject 
 
One SHS patient (subject 4) was added to this study to investigate if the 3D SB-CSI 
technique is sensitive to other respiratory diseases. In this case, the SHS presents 
spirometry values in the normal range (FEV1 predicted of 94% and FEV1/FVC of 0.76) 
and the gradient echo (GRE) ventilation images demonstrated a relatively homogenous gas 
distribution within the lung and throughout anterior to posterior slices (Figure 17A). 
 
Figure 16 Quantification of the ratio of Xe-129 dissolved in tissue to that in RBC maps of all subjects, in arbitrary units 
(AU). Each point corresponds to a ratio value of one slice of each subject, whose pulmonary function is expressed by a 
spirometry measurement (percentage of predicted FEV1). Subjects with the lowest predicted FEV1 values presented higher 
tissue/RBC ratios.  
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However, a mean value of 3.0±0.36 was obtained for the tissue/RBC ratio, which 
was similar to that obtained for the moderate-CF subject (3.0±0.36). Moreover, the 
regional information provided by the tissue/RBC ratio of each slice (Figure 17C) 
demonstrated a higher incidence of disease in the most anterior slices. This was consistent 
with the focal elevations in the He-3 apparent coefficient diffusion (ADC) prominent most 
anteriorly (Figure 17B).  
 
 
Figure 17 HP MR imaging lung measurements of the second-hand smoker subject (subject 4). (A) Ventilation maps 
obtained through a GRE sequence using Xe-129 as a contrast agent (TR 6.0 ms, TE 0.6 ms and in-plane resolution 
7.5x7.5 mm2). (B) He-3 apparent diffusion coefficient (ADC) maps (TR 9.7 ms, TE 6.3 ms, in-plane resolution 3x3 
mm2 and b-values 0 and 1.6 s/cm2). (C) Quantification of Xe-129 CSI maps that express the amount of gas dissolved in 
tissue to that in RBC, in arbitrary units (AU). CSI quantification shows an increase in the tissue/RBC ratio most 
prominent in anterior slices, consistent with disease observed in He-3 ADC maps (white arrows).  
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2.5 Discussion 
 
As seen in the preliminary clinical data, healthy subjects presented uniform 
ventilation and gas uptake-exchange in the parenchyma and in the RBC, as expected.  
This technique also detected a gradient from non-dependent (anterior) to dependent 
(posterior) regions of the lung. Since all subjects were imaged in the supine position, Xe-
129 signal increase from anterior to posterior slices may be attributable to the gravity 
dependent lung effect, as seen elsewhere [12, 16, 35].  
As predictable, the compression of the lung is more prominent in the gravitationally 
dependent portions, resulting in a higher tissue, alveoli and capillary density per unit 
volume of lung and thus increased amount of Xe-129 in those compartments. Gravity may 
also deform lung microstructure, producing smaller alveolar sizes, which results in higher 
alveolar surface-to-volume ratios in the dependent portion of the lung. The increase in this 
ratio should produce faster rates of transfer of Xe-129 into the tissue and blood. 
Gravitationally dependent gradients have also been detected through imaging of the HP 
He-3 ADC, which is sensitive to lung microstructure and consequently alveolar size [36].   
Regarding the CF subjects, regions of deficient ventilation and gas uptake-
exchange were visible within the lung. Structural abnormalities, such as bronchiectasis and 
inflammation of the bronchial walls, are thought to contribute to airflow obstruction in CF 
[30]. The fact that we were able to visualize regional abnormalities demonstrates that 
current resolution is sufficient to detect focal disease. In addition, the amount of defects in 
all lung compartment maps also appeared to be correlated with disease severity.  
The lack of gradients from anterior to posterior slices was also detected in the 
moderate-CF subject. This suggests that the uptake-exchange of the gas is not uniform 
throughout the lung in cases of disease.  
Most importantly, a lower and heterogeneous uptake-exchange of gas between the 
tissue and the RBC was observed in the CF population, demonstrated by higher values of 
median and STD of the tissue/RBC ratio. The increase in the ratio values of the this 
population indicated that Xe-129 did not reach the RBC in the same time scale or quantity 
as occurred in healthy lungs, likely a result of the thickening of the parenchyma, caused by 
characteristic inflammation seen in CF disease [26].  
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Assessing the pulmonary wall thickness has proven to be a reliable method to 
distinguish healthy from diseased subjects. In fact, by calculating the tissue/RBC ratio, we 
were able to reveal disease in the SHS subject, not detected by the lack of sensitivity of the 
pulmonary function tests and functional information of ventilation images. This suggests 
that this method is very sensitive and may be able to provide additional information that 
could be useful for diagnosing and monitoring pathologies affecting the pulmonary uptake-
exchange of gas, as when inflammation of lung parenchyma occurs. Since much of the 
research attention has focused on therapeutic anti-inflammatory strategies for the treatment 
of CF, the implementation of the 3D SB-CSI technique may be able to provide an earlier 
forecast of treatment response and outcomes. 
This technique also proved to be able to achieve very reproducible results both in 
disease as well as in healthy subjects. The CF population was expected to be associated 
with higher errors since subjects with pulmonary diseases have difficulty in reproducing 
respiratory movements [26].  
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Conclusion 
 
The preliminary results presented here let us hypothesize that the 3D SB-CSI 
technique may present improved sensitivity for the early detection and monitoring of 
several pulmonary diseases and conditions. Such method was able to generate ventilation 
maps that allowed assessment of gas distribution in the alveoli and correlated well with the 
existing imaging methods. Most importantly, 3D SB-CSI provided detailed 3D 
physiological information regarding gas uptake-exchange processes in a single and short 
breath-hold, capable of distinguishing healthy and diseased subjects. 
The current version of the 3D SB-CSI technique takes about 15 s to acquire 
18x18x8 voxels, with an in-plane resolution of about 18x18mm
2
. Further improvements, 
such as applying different techniques to reconstruct the maps, should provide additional 
temporal and spatial resolution, making this technique even more sensitive to small 
regional functional changes in the lung. The implementation of compressed-sensing data 
reconstruction methods may be capable of providing a significant acceleration by 
undersampling the data collected [37]. This could be important for the use of the 3D SB-
CSI technique in pediatric population with CF or in other subjects with severe pulmonary 
disease that may not be able to hold their breath for large periods of time.  
On the other hand, increased spectral resolution, in order to separate the tissue from 
the RBC peak, and thus measure precisely the fraction of Xe-129 dissolved in each 
compartment, would provide more sensitivity to this technique. According to Equation 4, 
the higher the magnetic field strength, the greater the separation in frequency of peaks will 
be. Therefore, a pilot study to determine whether 3 T is better suited for the 3D SB-CSI 
technique than the 1.5 T, would be appropriate. 
Regarding the method chosen to analyze the data, a more automatic process would 
be desirable to reduce quantification time and errors associated with manual data 
manipulation. The pulse sequence used in this study has already been applied in multiple 
animal studies showing good results in terms of variability of phase offset within the lung 
[18-21]. Translating to greater lung sizes may potentiate a higher degree of magnetic field 
inhomogeneities that could be corrected with improvements in RF pulse design. 
Optimizing the RF pulse would also reduce the artifacts related with the vibration of the 
diaphragm depicted in the ventilation map of Figure 14 (white arrow). Furthermore, care 
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should be taken in order to maintain the same FA profile for all subjects, so that 
normalization with the gas peak would be sensitive to disease.  
Finally, an exploratory study in a larger population is necessary to validate the 
results showed here. The results presented in this work may be used as guidance for future 
clinical studies using the 3D SB-CSI technique at the Department of Radiology and 
Medical Imaging of the University of Virginia. It is expected that in the next months more 
studies, focusing on CF disease as well as on chronic obstructive pulmonary disease, will 
be carried out there for validation of this technique.   
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